Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

NCT00944372 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

150

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment was difficult

Conditions

Solid Tumors

Interventions

DRUG: Indium In-111 pentetreotide

Sponsor

Mallinckrodt